Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation.
The report details the trend, potential and market size of Male Breast Cancer Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Male Breast Cancer Treatmentmarket, defines the market attractiveness level of Male Breast Cancer Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Male Breast Cancer Treatment industry, describes the types of Male Breast Cancer Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Male Breast Cancer Treatment market and the development prospects and opportunities of Male Breast Cancer Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Male Breast Cancer Treatment market in Chapter 13.
By Player:
AstraZeneca
Bristol-Myers Squibb
Bayer
Eli Lilly
BioNumerik Pharmaceuticals
Sun Pharmaceutical
Teva Pharmaceutical
Roche
Seattle Genetics
Accord Healthcare
Sanofi
Pfizer
Novartis
GlaxoSmithKline
By Type:
Medication
Chemotherapy
Others
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Male Breast Cancer Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Male Breast Cancer Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Male Breast Cancer Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Male Breast Cancer Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Male Breast Cancer Treatment Market Analysis and Outlook to 2022
-
7.1 Global Male Breast Cancer Treatment Consumption (2017-2022)
-
7.2 United States Male Breast Cancer Treatment Consumption (2017-2022)
-
7.3 Europe Male Breast Cancer Treatment Consumption (2017-2022)
-
7.4 China Male Breast Cancer Treatment Consumption (2017-2022)
-
7.5 Japan Male Breast Cancer Treatment Consumption (2017-2022)
-
7.6 India Male Breast Cancer Treatment Consumption (2017-2022)
-
7.7 South Korea Male Breast Cancer Treatment Consumption (2017-2022)
8 Region and Country-wise Male Breast Cancer Treatment Market Analysis and Outlook to 2028
-
8.1 Global Male Breast Cancer Treatment Consumption Forecast (2022-2028)
-
8.2 United States Male Breast Cancer Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Male Breast Cancer Treatment Consumption Forecast (2022-2028)
-
8.4 China Male Breast Cancer Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Male Breast Cancer Treatment Consumption Forecast (2022-2028)
-
8.6 India Male Breast Cancer Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Male Breast Cancer Treatment Consumption Forecast (2022-2028)
9 Global Male Breast Cancer Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Male Breast Cancer Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Medication Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Male Breast Cancer Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Male Breast Cancer Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Male Breast Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Medication Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Male Breast Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Male Breast Cancer Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Male Breast Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Male Breast Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Male Breast Cancer Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Male Breast Cancer Treatment Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Male Breast Cancer Treatment Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Male Breast Cancer Treatment Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Male Breast Cancer Treatment Product and Service
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Details
-
14.4.2 Eli Lilly Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly Male Breast Cancer Treatment Product and Service
-
14.5 BioNumerik Pharmaceuticals
-
14.5.1 BioNumerik Pharmaceuticals Company Details
-
14.5.2 BioNumerik Pharmaceuticals Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BioNumerik Pharmaceuticals Male Breast Cancer Treatment Product and Service
-
14.6 Sun Pharmaceutical
-
14.6.1 Sun Pharmaceutical Company Details
-
14.6.2 Sun Pharmaceutical Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sun Pharmaceutical Male Breast Cancer Treatment Product and Service
-
14.7 Teva Pharmaceutical
-
14.7.1 Teva Pharmaceutical Company Details
-
14.7.2 Teva Pharmaceutical Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Pharmaceutical Male Breast Cancer Treatment Product and Service
-
14.8 Roche
-
14.8.1 Roche Company Details
-
14.8.2 Roche Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Roche Male Breast Cancer Treatment Product and Service
-
14.9 Seattle Genetics
-
14.9.1 Seattle Genetics Company Details
-
14.9.2 Seattle Genetics Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Seattle Genetics Male Breast Cancer Treatment Product and Service
-
14.10 Accord Healthcare
-
14.10.1 Accord Healthcare Company Details
-
14.10.2 Accord Healthcare Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Accord Healthcare Male Breast Cancer Treatment Product and Service
-
14.11 Sanofi
-
14.11.1 Sanofi Company Details
-
14.11.2 Sanofi Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Sanofi Male Breast Cancer Treatment Product and Service
-
14.12 Pfizer
-
14.12.1 Pfizer Company Details
-
14.12.2 Pfizer Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Pfizer Male Breast Cancer Treatment Product and Service
-
14.13 Novartis
-
14.13.1 Novartis Company Details
-
14.13.2 Novartis Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Novartis Male Breast Cancer Treatment Product and Service
-
14.14 GlaxoSmithKline
-
14.14.1 GlaxoSmithKline Company Details
-
14.14.2 GlaxoSmithKline Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 GlaxoSmithKline Male Breast Cancer Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Male Breast Cancer Treatment
-
Figure Male Breast Cancer Treatment Picture
-
Table Global Male Breast Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Male Breast Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Male Breast Cancer Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Male Breast Cancer Treatment Consumption by Country (2017-2022)
-
Figure United States Male Breast Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Male Breast Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Male Breast Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Male Breast Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Male Breast Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Male Breast Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Male Breast Cancer Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Male Breast Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Male Breast Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Male Breast Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Male Breast Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Male Breast Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Male Breast Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medication Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Male Breast Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Male Breast Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Male Breast Cancer Treatment Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Male Breast Cancer Treatment Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Male Breast Cancer Treatment Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Male Breast Cancer Treatment Product and Service
-
Table BioNumerik Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table BioNumerik Pharmaceuticals Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioNumerik Pharmaceuticals Male Breast Cancer Treatment Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Male Breast Cancer Treatment Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Male Breast Cancer Treatment Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Male Breast Cancer Treatment Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Male Breast Cancer Treatment Product and Service
-
Table Accord Healthcare (Foundation Year, Company Profile and etc.)
-
Table Accord Healthcare Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Accord Healthcare Male Breast Cancer Treatment Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Male Breast Cancer Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Male Breast Cancer Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Male Breast Cancer Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Male Breast Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Male Breast Cancer Treatment Product and Service
-
